BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9018805)

  • 1. Coordinator's report: an assessment of the functional activity of human Rh monoclonal antibodies after their evaluation by nine laboratories.
    Kumpel BM
    Transfus Clin Biol; 1996; 3(6):439-52. PubMed ID: 9018805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator's report.
    Kumpel BM; Beliard R; Brossard Y; Edelman L; de Haas M; Jackson DJ; Kooyman P; Ligthart PC; Monchâtre E; Overbeeke MA; Puillandre P; de Romeuf C; Wilkes AM
    Transfus Clin Biol; 2002 Jan; 9(1):45-53. PubMed ID: 11889899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional activity of human Rh monoclonal antibodies (MABS).
    Kumpel BM
    J Immunogenet; 1990; 17(4-5):321-30. PubMed ID: 2128776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and functional activity of human Rh monoclonal antibodies.
    Kumpel BM; Jackson DJ
    Transfus Clin Biol; 1996; 3(6):453-8. PubMed ID: 9018806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human monoclonal anti-D antibodies. II. The relationship between IgG subclass, Gm allotype and Fc mediated function.
    Kumpel BM; Wiener E; Urbaniak SJ; Bradley BA
    Br J Haematol; 1989 Mar; 71(3):415-20. PubMed ID: 2539182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D.
    Kumpel BM
    Vox Sang; 1997; 72(1):45-51. PubMed ID: 9031501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes.
    Wiener E; Jolliffe VM; Scott HC; Kumpel BM; Thompson KM; Melamed MD; Hughes-Jones NC
    Immunology; 1988 Oct; 65(2):159-63. PubMed ID: 3192267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Rh monoclonal antibodies: assessment of functional activity by chemiluminescence and RhD antibody quantitation.
    Strachan AJ; Williams B; Mohabir L; Rowe GP
    Transfus Clin Biol; 1996; 3(6):483-7. PubMed ID: 9018813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-dependent cell-mediated cytotoxicity (ADCC) toward human O+ red cells coated with anti-D antibody: comparison between lymphocyte and monocyte ADCC activity.
    Sunada M; Suzuki S; Ota Z
    Acta Med Okayama; 1985 Apr; 39(2):77-89. PubMed ID: 3923782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions.
    Rozsnyay Z; Sármay G; Walker M; Maslanka K; Valasek Z; Jefferis R; Gergely J
    Immunology; 1989 Apr; 66(4):491-8. PubMed ID: 2523858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interactions of red cells sensitized by IgG1 and IgG3 human monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell lines.
    Kumpel BM; Hadley AG
    Mol Immunol; 1990 Mar; 27(3):247-56. PubMed ID: 2111455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in-vitro assessment of the functional activity of monoclonal anti-D.
    Hadley AG; Kumpel BM; Leader K; Merry AH; Brojer E; Zupanska B
    Clin Lab Haematol; 1989; 11(1):47-54. PubMed ID: 2495881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of IgG1 monoclonal anti-Rh(D): an investigation using ADCC and macrophage binding assays.
    Armstrong SS; Wiener E; Garner SF; Urbaniak SJ; Contreras M
    Br J Haematol; 1987 Jun; 66(2):257-62. PubMed ID: 3038161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh(D) antibodies.
    Hadley AG; Kumpel BM; Merry AH
    Clin Lab Haematol; 1988; 10(4):377-84. PubMed ID: 3150696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
    Hadley AG; Zupanska B; Kumpel BM; Leader KA
    Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of tests with different cellular bioassays in relation to severity of RhD haemolytic disease. Report from nine collaborating laboratories.
    Vox Sang; 1991; 60(4):225-9. PubMed ID: 1926829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of blending IgG1 and IgG3 monoclonal anti-D in promoting the metabolic response of monocytes to sensitized red cells.
    Hadley AG; Kumpel BM
    Immunology; 1989 Aug; 67(4):550-2. PubMed ID: 2504663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.
    Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB
    Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functional activity of human monocytes passively sensitized with monoclonal anti-D suggests a novel role for Fc gamma RI in the immune destruction of blood cells.
    Griffiths HL; Kumpel BM; Elson CJ; Hadley AG
    Immunology; 1994 Nov; 83(3):370-7. PubMed ID: 7835961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a panel of human monoclonal antibodies to D and exploration of the synergistic effects of blending IgG1 and IgG3 antibodies on their in vitro biologic function.
    Armstrong-Fisher SS; Carter MC; Downing I; Fraser RH; Inglis GE; Allan EK; Mackie A; Prowse CV; Templeton JG; Thorpe SJ; Urbaniak SJ
    Transfusion; 1999 Sep; 39(9):1005-12. PubMed ID: 10533828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.